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ABSTRACT  
Poly-N-acetylglucosamine (PNAG) is a major component of the Staphylococcus epidermidis 
biofilm extracellular matrix. However, it is not yet clear how this polysaccharide impacts the 
host immune response and infection-associated pathology. Faster neutrophil recruitment 
and bacterial clearance were observed in mice challenged intraperitoneally with S. 
epidermidis biofilm cells of the PNAG-producing 9142 strain than in mice similarly 
challenged with the isogenic PNAG-defective M10 mutant. Moreover, intraperitoneal priming 
with 9142 cells exacerbated liver inflammatory pathology induced by a subsequent 
intravenous S. epidermidis challenge, compared to priming with M10 cells. The 9142-primed 
mice had elevated splenic CD4(+) T cells producing gamma interferon and interleukin-17A, 
indicating that PNAG promoted cell-mediated immunity. Curiously, despite having more 
marked liver tissue pathology, 9142-primed mice also had splenic T regulatory cells with 
greater suppressive activity than those of their M10-primed counterparts. By showing that 
PNAG production by S. epidermidis biofilm cells exacerbates host inflammatory pathology, 
these results together suggest that this polysaccharide contributes to the clinical features 
associated with biofilm-derived infections. 
INTRODUCTION  
Staphylococcus epidermidis is a commensal bacterium of human skin and mucous 
membranes (1). The ability to establish biofilms on the surfaces of indwelling medical devices 
is a major virulence mechanism of this bacterium, which is the most commonly isolated 
etiological agent of nosocomial infections (2). S. epidermidis biofilm formation involves initial 
cellular adherence to a surface, followed by intercellular aggregation and accumulation in 
multilayer cell clusters (1). This process is dependent on adhesive extracellular molecules (3) 
such as poly-N-acetylglucosamine (PNAG). PNAG is a major factor mediating cell-to-cell 
adhesion in staphylococci (4, 5), and its production depends on genes encoded within the 
intercellular adhesion (ica) locus (6). The final stage of the biofilm life cycle comprises cell 
disassembly and subsequent growth in a planktonic mode, a process contributing to S. 
epidermidis biofilm pathogenesis by disseminating infection (7). 
S. epidermidis strains with impaired PNAG production display attenuated virulence in foreign 
body infection models (8, 9), while the production of this polysaccharide conferred a survival 
advantage on this bacterium infecting the nematode host Caenorhabditis elegans (10). 
Moreover, ica mutants display growth attenuation when competing in vivo with the 
corresponding wild-type (WT) strains (11) and commensal ica-negative strains became 
invasive when transformed with a plasmid containing the ica locus (12). In the clinical setting, 
the presence of icaA/D genes was associated with therapeutic failure in device-related 
infections with coagulase-negative staphylococci (13). Despite the observed association of 
PNAG production with S. epidermidis virulence, it is not entirely clear how this polysaccharide 
may affect the host immune response. Previous reports have shown that PNAG stimulates the 
production of proinflammatory mediators (14, 15) but also that it impairs phagocytosis and 
phagocyte-mediated bacterial killing (16,–18). Additionally, little is known about the effects of 
this polysaccharide on acquired immunity. Here, by using the PNAG-producing S. epidermidis 
9142 strain and a PNAG-negative isogenic M10 mutant, we have addressed in the murine 
model how this polysaccharide affected the host inflammatory response. The results obtained 
show that mice infected with a PNAG-producing S. epidermidis strain exhibited a more intense 
inflammatory response than mice infected with an isogenic PNAG-negative mutant. 
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MATERIALS AND METHODS 
Bacteria and growth conditions. Biofilm-forming S. epidermidis strain 9142 (19) and the 
isogenic PNAG-negative M10 mutant (5) were used. Absence of growth defects in the M10 
strain was confirmed, as the two strains had similar generation times, as determined by 
growing 9142 and M10 bacteria in tryptic soy broth (TSB; Merck, Darmstadt, Germany). 
Abrogation of PNAG production in M10 cells was confirmed by flow cytometry (see Fig. S1 in 
the supplemental material). To prepare bacterial suspensions for inoculation, both strains 
were grown simultaneously for 48 h in TSB under biofilm-inducing conditions as previously 
described (20). Additionally, 48-h 9142 biofilm culture supernatants were recovered to collect 
biofilm-released cells (21), designated S-9142 cells here. For details of the methods used, see 
Fig. S2 in the supplemental material. Bacterial suspensions were mildly sonicated to 
dissociate cell clusters and create a homogeneous suspension. Cell concentrations and 
viability were determined by flow cytometry by previously described methods (20). 
 
Mice. Male BALB/c mice 8 to 12 weeks old were purchased from Charles River and housed at 
the animal facilities of ICBAS-UP. Interleukin-10 (IL-10)-deficient (Il10
−/−
) BALB/c mice 8 to 12 
weeks old were kindly provided by Anne O'Garra (National Institute for Medical Research, 
London, United Kingdom) and housed at the animal facilities of IBMC. Procedures were 
performed according to the 86/609/EEC Directive and Portuguese rules (DL 129/92) and were 
approved by the competent national board (DGV, document 0420/000/000/2010). 
 
Infections and collection of biological samples. For analysis of early inflammatory 
responses, mice were infected intraperitoneally (i.p.) with 2 × 10
8
 live 9142 or M10 cells or 
sham infected with phosphate-buffered saline (PBS). Animals were anesthetized with 
isoflurane (Abbott House, Berkshire, United Kingdom) for terminal blood collection and 
euthanasia. Peritoneal exudates were recovered in 5 ml of cold PBS. Exudates contaminated 
with blood were excluded. Collected cells were used for flow cytometry analysis. Livers were 
collected in PBS, disrupted with a Potter homogenizer, serially diluted, and plated on tryptic 
soy agar (Merck) for enumeration of CFU. To analyze the induction of acquired immunity, 
BALB/c mice were primed twice i.p. at 1-week intervals with 1 × 10
6
 live 9142 or M10 cells or 
PBS alone. Control groups were not subjected to further treatment (9142/−, M10/−, or PBS/− 
mice, respectively). Seven days after the last i.p. immunization, mice from all groups were also 
intravenously (i.v.) challenged with 1 × 10
8
 CFU of S-9142 bacteria (9142/S-9142, M10/S-
9142, and PBS/S-9142 mice). Four and 9 days after infection, animals were anesthetized for 
blood collection and euthanized as described above. Spleens were removed and 
homogenized to single-cell suspensions in Hanks' balanced salt solution (Sigma) for further 
use in flow cytometry and in vitro suppression assays. Livers were also collected and used for 
CFU counting or histopathologic analysis. Il10
−/−
 mice were similarly tested but challenged i.v. 
with 1 × 10
7
 S-9142 bacteria. Experimental mouse groups are schematically described in Fig. 
S2 in the supplemental material. 
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Flow cytometry analysis. Flow cytometry analysis was performed with an EPICS XL flow 
cytometer with the EXPO32ADC software (Beckman Coulter, Miami, FL). A subset of a total of 
1 × 10
6
 leukocytes was stained per sample. The following anti-mouse monoclonal antibodies 
(MAbs), along with the respective isotype controls, were used: F4/80 antigen (BM8), Foxp3 
(FJK-16S) (both from eBioscience, San Diego, CA), CD4 (RM4-5), Ly-6G (1A8), Ly-6C (AL-
21), CD25 (PC61), gamma interferon (IFN-γ) (XMG1.2), IL-4 (BVD4-11B11), IL-17A (TC11-
18H10), and IL-10 (JES5-2A5) (all from BD Pharmingen, San Diego, CA, USA). For 
intracellular cytokine detection, cells were stimulated with phorbol myristate acetate and 
ionomycin in the presence of brefeldin A as previously described (22). Detection of surface 
cell markers and intracellular Foxp3 was performed also as previously described (22). The 
collected data files were analyzed with FlowJo software version vX.0.7 (Tree Star Inc., 
Ashland, OR, USA). 
 
Cytokine measurements. The concentrations of CXCL-1, CXCL-2, tumor necrosis factor 
alpha (TNF-α), IL-6, IL-10, IL-12p70, IFN-γ, and IL-17A in peritoneal exudates or serum 
samples were evaluated with commercial enzyme-linked immunosorbent assay (ELISA) kits 
(Duo-Set; R&D Systems, Minneapolis, MN, USA). 
 
Antibody titer quantification. S. epidermidis-specific serum IgG antibody titers were 
quantified by ELISA and calculated by endpoint titration of serial dilutions. ELISA plates 
(MaxiSorp; Nunc, Roskilde, Denmark) were coated with isopropanol-fixed S-9142 cells at 1 × 
10
6
/well. Bound serum antibodies were detected with alkaline phosphatase-coupled goat anti-
mouse anti-IgG1, -IgG2a, or -IgG3 (Southern Biotechnology Associates, Birmingham, AL, 
USA). 
 
IFN-γ neutralization. To neutralize IFN-γ, mice were i.v. injected in the tail vein 1 h prior to 
infection (performed as described above) with 500 μg of an IFN-γ-specific MAb (clone R4-
6A2) or a rat IgG1 isotype control (clone HRPM), both from BioXcell, West Lebanon, NH, 
USA. 
 
Cell cultures and suppression assays. In vitro suppression assays were performed 
according to a modification of previously described methods (22). Briefly, antigen-presenting 
cells (APC) were prepared from splenic cell suspensions of naive mice. Total CD4
+
, CD4
+
 
CD25
−
, and CD4
+
 CD25
+
 cells from noninfected and infected mice were isolated from pooled 
spleen cells of five mice with a magnetic cell sorting CD4
+
 CD25
+
 T-cell isolation kit (Miltenyi 
Biotech, Inc., Auburn, CA, USA). Naive, carboxyfluorescein succinimidyl ester (CFSE)-
labeled, CD4
+
 CD25
−
 T cells (responder cells) were plated at 2.5 × 10
4
/well into U-shaped 96-
well plates together with 10
5
 APC and 1 μg/ml anti-CD3 MAb (positive controls). Cells without 
the anti-CD3 stimulus were used as negative controls. CD4
+
 CD25
+
 T cells from the different 
groups analyzed were added at different CD4
+
 CD25
+
-to-responder T-cell ratios (1:1, 0.5:1, 
0.2:1, and 0.1:1). Each condition was set in sextuplicate, and cultures were maintained for 72 
h at 37°C and 5% CO2. Proliferation and suppression were determined on the basis of CFSE 
fluorescence by flow cytometric analysis in an EPICS XL flow cytometer (Beckman-Coulter). 
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Histopathologic examination and immunohistochemistry. Livers were fixed in buffered 
formalin and embedded in paraffin for hematoxylin-eosin (HE) histopathologic analysis or 
Foxp3 detection by immunohistochemistry as previously described (23). For histopathologic 
analysis of WT and Il10
−/−
 mice, five micrographs at ×100 magnification, from five different 
liver lobes, were randomly taken from each tissue slide sample. The number of cellular 
infiltrate clusters was determined with ImageJ software (National Institutes of Health, 
Bethesda, MD). For Foxp3 detection in either WT or Il10
−/−
 mice, representative micrographs 
of each tissue slide sample were taken at ×400 magnification. 
Statistical analysis. Statistical significance of results was determined by one-way analysis of 
variance (ANOVA) and Tukey's post hoc test. Statistical analysis was performed with 
GraphPad Prism 5 Software (GraphPad Software, Inc., La Jolla, CA, USA). P values of <0.05 
were considered statistically significant. 
RESULTS 
Inflammatory response in mice infected with 9142 or M10 S. epidermidis. To assess the 
effect of PNAG production on the early inflammatory response to S. epidermidis infection, 
peritoneal exudates were recovered from mice 2 and 6 h after infection with 9142 or M10 or 
from PBS-treated controls. Higher levels of the neutrophil-chemokine attractant CXCL-1 were 
found in the exudates of infected mice than in those of controls (Fig. 1A). CXCL-2 levels were 
found transiently above control values in both infected mouse groups, albeit not reaching 
statistical significance. In accordance with these findings, neutrophils, defined as Ly6G
high
 
Ly6C
low/int
 F4/80
neg/low
 cells (24), were rapidly recruited into the peritoneal cavities of all 
infected animals (Fig. 2A and andB).B). Two hours after infection, higher numbers of recruited 
neutrophils were found in mice infected with 9142 than in M10-infected mice, while the 
reverse was observed by 6 h postinfection (Fig. 2B). The levels of the proinflammatory 
cytokines TNF-α, IL-6, and IL-12p70, as well as of antiinflammatory IL-10, were also assessed 
in the peritoneal lavage fluids. Both infected mouse groups showed elevated IL-6 levels, which 
were higher in 9142-infected mice (Fig. 1A). Serum IL-6 was also found to be elevated in both 
infected groups (Fig. 1B). The IL-10 concentration was found slightly above control levels in 
peritoneal exudates obtained from both infected groups at 2 h postinfection, while serum IL-10 
was detected above control levels only in 9142-infected mice (Fig. 1A and andB,B, 
respectively). No increase in TNF-α and IL-12p70 levels was detected in either the sera or 
peritoneal exudates (data not shown). As shown in Fig. 2C and andD,D, the loads of the two 
bacterial strains in the peritoneal exudates and livers were similar at 2 h postinfection, but the 
elimination of strain 9142 was faster at 6 h than that of strain M10. S. epidermidis CFU were 
no longer detected in any group 24 h after infection. These results together show that PNAG 
expression promotes faster recruitment of neutrophils and improved bacterial clearance. 
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Acquired immune response in mice primed with 9142 or M10 S. epidermidis. We next 
used a prime-boost strategy with PNAG-producing or -nonproducing bacteria to assess how 
this polysaccharide affected the adaptive immune response to S. epidermidis infection. Since 
biofilm-derived cells can disseminate hematogenously (25), we used an i.v. challenge model. 
BALB/c mice were primed with S. epidermidis 9142 or M10 cells grown under biofilm-inducing 
conditions and challenged i.v. with S-9142 cells. Unexpectedly, prior immunization with either 
strain made mice more susceptible to an i.v. challenge, preventing prompt elimination of the 
pathogen (see Table S1 in the supplemental material). To understand the basis of this 
phenomenon, we analyzed a series of immune parameters. Prior immunization with either 
strain increased the S. epidermidis-specific IgG titers (Fig. 3), suggesting that there was no 
impairment of antibody responses. We found evidence of an enhanced T-cell response in 
mice immunized with strain 9142. As shown in Fig. 4, these mice presented higher proportions 
and numbers of splenic IFN-γ
+
 CD4
+
 and IL-17A
+
 CD4
+
 T cells than mice primed with M10 or 
the PBS-treated controls. No increase in IL-4- or IL-10-expressing CD4
+
 T cells appeared to 
be promoted by immunization. No significant elevation of serum IFN-γ or IL17A was found in 
immunized mice compared to the control group (see Fig. S3 in the supplemental material). 
 
Effect of PNAG production on liver inflammatory pathology. Liver histopathology was 
analyzed in the infected mice, as this organ is a preferred target in i.v. S. epidermidis infection 
(26). No bacteria could be found in the nonchallenged control groups, and their livers 
presented no significant histological alterations (see Fig. S4 in the supplemental material). 
Challenged mice showed liver lesions that were more numerous and occupied a larger area in 
mice previously immunized by either strain than in PBS-treated controls. Immunization with 
strain 9142 led to a more intense inflammatory response than immunization with strain M10 
(Fig. 5A and andB).B). Mice from the former group showed well-defined granulomas, and rare 
plasma cells were also observed (see Fig. S5 in the supplemental material). The presence of 
polymorphonuclear cells (two or three per high-power magnification field) was also observed 
(Fig. 5C). In mice immunized with M10, the infiltration remained mostly lymphocytic. Mitotic 
hepatocytes and large necrotic areas were observed in two animals immunized with strain 
9142, both at the periphery and in the parenchyma of the tissue (Fig. 5C). At day 9 after the 
i.v. challenge, 9142/S-9142 mice still presented the more marked inflammatory response (see 
Fig. S6 in the supplemental material). Together, these findings confirmed the proinflammatory 
effect of bacterial PNAG production. As IFN-γ has been associated with the formation of 
granulomas (27), we next evaluated the effect of neutralizing this cytokine in the i.v. infected 
mice. Surprisingly, as shown in Fig. S7 in the supplemental material, bacterium-primed mice 
treated with a neutralizing anti-IFN-γ MAb before the i.v. challenge presented higher numbers 
of liver infiltrates than isotype control-treated counterparts. This result indicates a rather 
protective role for IFN-γ in the observed liver histopathology. 
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Suppressive activity of regulatory T cells in S. epidermidis-infected mice. We next 
investigated whether the proinflammatory role of PNAG could result from impaired regulatory 
T-cell (Treg cell) responses or function. As shown in Fig. S7 in the supplemental material, no 
significant differences were found among the different mouse groups in the proportions of 
splenic Foxp3-expressing CD4
+
 CD25
+
 or CD4
+
 CD25
−
 T cells or in Foxp3 expression levels 
in those populations. This indicates that PNAG did not induce T-cell differentiation into a Treg 
phenotype. However, splenic CD4
+
 CD25
+
 T cells sorted from 9142-immunized mice, and 
mostly containing Foxp3
+
 cells (see Fig. S7), displayed a greater capacity to suppress anti-
CD3 MAb-induced proliferation of CD4
+
 CD25
−
 responders than did counterparts obtained 
from control or M10-immune mice (Fig. 6). IL-10 was previously implicated in the suppressive 
function and stability of Tregs (28). Therefore, we investigated whether the higher suppressive 
activity of Tregs promoted by PNAG could be observed in Il10
−/−
 mice. Notably, an inoculum of 
2 × 10
8
 S. epidermidis 9142 injected i.v., as used in WT mice, resulted in 100% mortality in 
Il10
−/−
 mice. Thus, in subsequent studies, a 10-fold smaller dose was used for infections. 
Il10
−/−
 mice immunized with either S. epidermidis strain developed liver pathology similar to 
that observed in WT mouse counterparts challenged with a greater bacterial load, with 
formation of granulomas (Fig. 7A and andB).B). Compared to nonimmune controls, mice 
immunized with strain 9142 showed significant changes in cellular composition and an 
increase in the number of granulomas (Fig. 7A; see Fig. S5 in the supplemental material), as 
well as larger necrotic areas (Fig. 7C). As shown in Fig. 6, the greater suppressive activity 
displayed by Tregs obtained from the 9142-immune group was no longer observed in Il10
−/−
 
mice. As in the WT mice, the proportions of splenic Foxp3
+
 CD4
+
 CD25
+
 and CD4
+
 CD25
−
 T 
cells were similar among the different mouse groups (see Fig. S8 in the supplemental 
material). These results implicate IL-10 in the generation of Tregs with higher suppressive 
activity detected in mice infected with 9142 bacteria. We next evaluated whether Foxp3
+
 cells 
could be differently recruited into lesions observed in the livers of the different i.v. infected 
groups. As shown in Fig. S9 in the supplemental material, rare or no Foxp3
+
 cells were 
detected in the lesions or surrounding tissue of all infected mice. These results show that 
although PNAG promoted the generation of Tregs with greater suppressive capacity, these 
cells were scarcely or not at all recruited into the hepatic lesions. 
DISCUSSION 
The PNAG homopolymer was initially shown to mediate intercellular adhesion of S. 
epidermidis biofilm cells (5) and to protect this bacterium from humoral and cellular immune 
mechanisms (16,–18). Here we describe a proinflammatory effect of S. epidermidis PNAG. 
Mice inoculated i.p. with biofilm-grown S. epidermidis cells readily responded by recruiting 
neutrophils into the peritoneal cavity. The elevated levels of CXCL-1 and CXCL-2 detected in 
the peritoneal exudates of infected mice might have contributed to the neutrophil influx. S. 
epidermidis-induced production of CXCL-2 by human osteoblasts or murine epithelial cells 
and raised blood CXCL-1 levels have also been reported (29,–31). Yet higher numbers of 
neutrophils were recruited into the peritoneal cavity in response to PNAG-positive strain 9142 
than in response to PNAG-negative strain M10 in the very first hours following infection, thus 
explaining the faster bacterial clearance detected in the former infection. Nevertheless, at 24 h 
after infection, bacteria were already cleared by both mouse groups, in agreement with the 
low virulence usually attributed to S. epidermidis (1). Previous studies have shown that PNAG 
production may promote bacterial persistence in S. epidermidis-infected rodents (8, 9). This is 
in apparent contrast to the observation reported here of faster bacterial clearance of PNAG-
producing bacteria. This discrepancy may be due to the device-associated biofilm infection 
 Version: Postprint (identical content as published paper) This is a self-archived document from i3S – Instituto de 
Investigação e Inovação em Saúde in the University of Porto Open Repository For Open Access to more of our 
publications, please visit http://repositorio-aberto.up.pt/  
 
A
0
1
/0
0
 
model used in those studies instead of an i.p. established infection that does not promotes 
biofilm formation. 
PBS-treated mice could control an i.v. infection with S. epidermidis originating from biofilms 
while developing only mild inflammatory pathology in the liver. Strikingly, priming with a small 
dose of biofilm-grown bacteria significantly exacerbated the hepatic inflammatory 
consequences of an i.v. challenge. Deleterious effects on the liver have also been observed in 
mice repeatedly challenged with S. epidermidis (32), indicating that chronic or repeated 
exposure to even at a small dose of this pathogen may significantly impact the usual harmless 
character of this bacterium. However, rare liver abscesses due to S. epidermidis infection 
have also been reported in human patients (33,–36). 
We observed here that S. epidermidis-infected mice responded by producing IFN-γ, in 
agreement with previous studies showing that murine dendritic cells challenged with 9142 
biofilm cells secreted the IFN-γ-inducing cytokine IL-12 (37). Interestingly, although similar 
levels of IFN-γ were found in the serum of mice primed with either strain 9142 or M10, the 
former gave rise to higher frequencies of splenic IFN-γ-producing CD4
+
 T cells, indicating that 
PNAG on the bacterial cell promoted the differentiation of T cells producing this cytokine. IFN-
γ may contribute to hepatocyte damage directly or indirectly through liver macrophage 
activation (38). Therefore, by favoring IFN-γ production, S. epidermidis PNAG could have 
contributed to the exacerbated liver inflammatory pathology observed in strain 9142-primed 
mice. The formation of granulomas observed in these mice further suggests the involvement 
of IFN-γ, as an important role for this cytokine in the organization of these inflammatory 
structures was previously reported (27). Production of IFN-γ, among other proinflammatory 
cytokines, has also been associated with clinical inflammation observed in S. epidermidis-
induced experimental endophthalmitis (39). Nevertheless, antibody-mediated neutralization of 
IFN-γ indicates that this cytokine can actually be contributing to the control of the observed 
inflammatory pathology. 
S. epidermidis 9142-primed mice also showed the highest frequencies of splenic IL-17A
+
 
CD4
+
 T cells. IL-17 produced during bacterial infections has been associated with host 
protection rather than with hepatic damage (26, 40). However, studies investigating chronic 
bacterial infections (41, 42) or repeated immunization with mycobacterial antigens (43) have 
shown that this cytokine may contribute to immune-mediated tissue damage. Taking into 
account the recalcitrant nature of biofilm-originating infections, further studies will help 
elucidate whether IL-17A may affect host tissue integrity during these infections. IL-17-
mediated pathology is usually associated with neutrophilic inflammation (43); however, this 
cytokine may also promote the formation of mononuclear cell granulomas (44). Therefore, a 
role for IL-17A in contributing to the formation of the hepatic lesions observed cannot be ruled 
out. It would be important to determine if there is a causal relationship between a 
granulomatous response and enhanced susceptibility to infection, as was suggested by some 
in zebrafish models of tuberculosis (45). 
In apparent contrast to the proinflammatory effect of PNAG, Tregs from mice primed with 
PNAG-positive strain 9142 displayed greater suppressive activity than those primed with 
PNAG-negative strain M10 or control nonimmunized mice. The generation of Tregs with 
enhanced suppressive activity was also reported in studies related to other pathogens (22, 46) 
and may thus be a general phenomenon associated with infectious conditions. Nevertheless, 
a previous study showed that extracellular products of S. epidermidis promoted the 
suppressive activity of human Tregs (47), further indicating that this cell population may be 
involved in counterinflammatory mechanisms operating during infections with this bacterium. 
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Tregs were recently shown to be crucial for establishing S. epidermidis skin commensalism 
(48). Taking our results into account, it will also be interesting to ascertain in future studies 
whether Tregs may contribute to the persistence of biofilm-related S. epidermidis infections 
(49). A limited role for Tregs in sustaining chronic S. aureus infection was previously reported 
(50). In the experimental model used here, the generation of Tregs with enhanced 
suppressive capacity depended on PNAG and IL-10. Production of IL-10 was favored by 
PNAG expression, as higher levels of this cytokine were found in the serum of mice 
challenged i.p. with PNAG-producing bacteria. Elevated IL-10 production in patients with 
staphylococcal bacteremia has been associated with an increased mortality rate, likely 
because of impaired immunity (51). However, as PNAG expression did not impair the 
clearance of 9142 bacteria while inducing IL-10 production, our results do not suggest a major 
role for this cytokine in the impairment of host immunity to S. epidermidis. The higher 
susceptibility to infection displayed by Il10
−/−
 mice, which presented a more severe 
inflammatory pathology than WT counterparts, even when challenged with a 10-fold smaller 
dose of S. epidermidis, indicates that IL-10 may be more important in limiting excessive 
inflammation than in promoting bacterial persistence. Tregs are important in controlling 
excessive inflammation resulting from microbial infections (52). Therefore, it was somewhat 
surprising that mice of the 9142/S-9142 group simultaneously presented highly suppressive 
Tregs and more marked liver tissue damage. A possible explanation may reside in the 
observed lack of Foxp3
+
 cell recruitment into lesions. 
S. epidermidis is a major cause of nosocomial bloodstream infections (53). Dispersal of 
biofilm-derived cells is thought to contribute significantly to the pathogenesis of systemic 
infections (54). Our results suggest that PNAG may contribute to pathogenesis by 
exacerbating the inflammatory response resulting from bacteremia. Previous reports have 
associated PNAG production with S. epidermidis virulence, mainly by assessing bacterial 
loads in target organs (9). Our results also implicate PNAG in the inflammatory pathology 
often associated with S. epidermidis infections (49). Moreover, by showing that this 
polysaccharide may exacerbate host tissue damage resulting from bacterial antigen priming, 
we unveiled another property of PNAG that may impact PNAG-targeted vaccination 
strategies. Together, by showing that PNAG may simultaneously contribute to pro- and 
counterinflammatory mechanisms, the results presented here highlight the complex balance of 
the immune response elicited by S. epidermidis (14). 
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FIGURES 
 
Figure 1. Cytokine production 2 h and 6 h following i.p. infection with S. epidermidis cells. Levels of (A) CXCL1, 
CXCL2, IL-6 and IL-10, as indicated, in peritoneal exudates and (B) IL-6 and IL-10 in the serum of S. epidermidis 
9142-, M10- or PBS-injected mice. Results correspond to pooled data of three independent experiments for each 
time-point analyzed. Each dot represents an individual mouse. Horizontal lines in each group represent the mean 
value; ND – Not detected above detection limit. (One-way ANOVA, p<0.05; Tukey’s post-hoc test: *p<0.05; ** 
p<0.01; ***p<0.001)  
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Figure 2. Neutrophil and CFU counts of S. epidermidis in the peritoneal cavity 2 h and 6 h after infection. (A) Contour 
plots representative of the gating strategy used to define neutrophils (Ly6G high, Ly6C low/int, F4/80 neg/low) and 
(B) number of neutrophils in peritoneal exudates of S. epidermidis 9142-, M10- or PBS-injected mouse groups (One-
way ANOVA, p<0.05; Tukey’s post-hoc test: * p<0.05; ** p<0.01; *** p<0.001). Number of CFU recovered at the 
indicated time-points after infection in: (C) peritoneal exudates and (D) livers of the same mouse groups. Results 
correspond to pooled data of three independent experiments for each time-point analyzed. Each dot represents an 
individual mouse. Horizontal lines in each group represent the mean value (One-way ANOVA, p<0.05; Tukey’s post-
hoc test: * p<0.05; ** p<0.01; *** p<0.001). 
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Figure 3. Serum levels of S. epidermidis-specific IgG1, IgG2a and IgG3 detected in S. epidermidis immunized and 
challenged mice given the immunization/challenge combinations: 9142/S-9142, M10/S-9142 or PBS/S-9142. IgG 
titers were determined in serum samples collected 4 days after the i.v. infection using isopropanol-fixed-S-9142 cells 
as the antigen to coat ELISA plates. Data are presented as log10 of the antibody titers, as indicated. Results 
correspond to pooled data of three independent experiments. Each dot represents an individual mouse. Horizontal 
lines in each group represent the mean value (One-way ANOVA, p<0.05; Tukey’s post-hoc test; * p<0.05; ** p<0.01; 
*** p<0.001). 
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Figure 4. Proportions of splenic CD4+ T cells producing IFN-γ and IL-17A. (A) Gating strategy and representative 
examples of flow cytometry analysis of CD4+ T cells expressing IFN-γ, IL-17A, IL-10 and IL-4. (B) Proportions and 
(C) numbers of IFN-γ+CD4+ or IL-17A+CD4+ T cells within total CD4+ T cells detected 4 days upon the i.v. infection 
in 9142/S-9142, M10/S-9142 and PBS/S-9142 mouse groups. Numbers within contour plots correspond to the 
frequency of gated cells in each example shown. Results correspond to pooled data of two independent experiments. 
Each dot corresponds to an individual mouse. Horizontal lines in each group represent the mean value (One-way 
ANOVA, p<0.05; Tukey’s post-hoc test: * p<0.05; *** p<0.001).  
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Figure 5. Analysis of liver histology in WT mice. (A) Quantitative analysis of the number of cellular infiltrates and 
percentage of the area containing cellular infiltrates per 0.6 mm
2
 in the livers of WT mice immunized then challenged 
with the combination of S. epidermidis 9142/S-9142, M10/S-9142 or PBS/S-9142 groups, 4 days after i.v. infection. 
Bars represent means plus one SD of 6 liver samples from each mouse group from which 5 micrographs from 5 
different liver lobes were randomly taken at 100× magnification. (B) Representative hematoxylin-eosin staining 
examples of livers from the mouse groups described above, as indicated in the figure. (C) Representative 
micrographs of infiltrating neutrophils, necrotic areas and hepatocyte mitosis, in the left middle and right micrographs, 
respectively, observed in the S. epidermidis immunized then challenged 9142/S-9142 mouse group. Arrows in (B) 
indicate cell infiltrate clusters and in (C) neutrophil, necrotic area and dividing hepatocyte, respectively. Bar = 200μm 
or 20 μm as indicated (One-way ANOVA, p<0.05; Tukey’s post-hoc test; * p<0.05; ** p<0.01; *** p<0.001).  
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Figure 6. Flow cytometric evaluation of anti-CD3 mAb-induced proliferative response of 2.5 × 10
4 
CFSE-labeled 
splenic naïve CD4+CD25- T (responder) cells cultured for 72 h with 10
5 
irradiated APC, in the absence or presence 
of splenic CD4+CD25+ T cells sorted from pooled splenic cells of 3-5 mice per group of 9142/S-9142, M10/S-9142 
and PBS/S-9142 WT and Il10-/- mice, as indicated. Negative control corresponds to responder cells with no mAb 
added and positive control corresponds to responder cells cultured with mAb and without splenic CD4+CD25+ T 
cells. (A) Histograms are representative examples out of three independent experiments and correspond to 5:1 ratio 
between responder and CD4+CD25+ T cells. Values in each graph indicate the percentage of cells that divided at 
least once. (B) Percentage of relative suppression exerted by CD4+CD25+ T cells on the proliferative ability of 
responder cells. Bars correspond to means plus one SD of data pooled from three independent experiments. 
Statistical significance between mouse groups is indicated above bars (one-way ANOVA, p<0.05; Tukey’s post-hoc 
test; * p<0.05).  
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Figure 7. Analysis of liver histology in Il10-/- mice. (A) Quantitative analysis of the number of cellular infiltrates and 
percentage of area containing cellular infiltrates per 0.6 mm
2 
observed 4 days after i.v. infection in the livers of Il10-/- 
mice from S. epidermidis immunized then challenged 9142/S-9142, M10/S-9142 or PBS/S-9142 groups. Bars 
represent means plus one SD of 6 liver samples from each Il10-/- mouse group from which 5 micrographs from 5 
different liver lobes were randomly taken at 100× magnification. (B) Representative hematoxylin-eosin liver staining 
examples of the mouse groups described above, as indicated in the figure. (C) Representative micrographs at 400× 
of necrotic areas observed in S. epidermidis immunized then challenged 9142/S-9142 Il10-/- mice. Arrows in (B) 
indicate cell infiltrate clusters and in (C) necrotic area. Bar = 200μm. (One-way ANOVA, p<0.05; Tukey’s post-hoc 
test; ** p<0.01; *** p<0.001).  
 
